Related Experiment Video
Updated: Jul 15, 2026
06:31
Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Understanding the minimum clinically important difference: a review of concepts and methods.
Anne G Copay1, Brian R Subach, Steven D Glassman
1The Spinal Research Foundation, 1831 Wiehle Avenue, Suite 200, Reston, VA 20190, USA. acopay@spinemd.com
Summary
Determining the minimum clinically important difference (MCID) in spinal surgery is crucial for assessing treatment effectiveness. Current methods have limitations, highlighting the need for improved MCID determination strategies.
Area of Science:
- Spine surgery outcomes research
- Clinical trial methodology
- Patient-reported outcome measures (PROMs)
Background:
- Patient-reported outcomes (PROs) are key to evaluating spinal surgery effectiveness.
- The minimum clinically important difference (MCID) signifies the smallest patient-valued improvement.
- MCID is proposed as a standard for treatment effectiveness and patient satisfaction.
Purpose of the Study:
- To review existing definitions of MCID.
- To examine methods for determining MCID.
Main Methods:
- Review of anchor-based and distribution-based methods for MCID determination.
- Detailed examination of subdivisions within each method.
- Analysis of limitations, assumptions, and biases of MCID determination.
Main Results:
- All MCID determination methods possess specific shortcomings.
- Key limitations include multiple MCID calculations, loss of patient perspective, and baseline score influence.
- Accurate MCID determination faces challenges.
Conclusions:
- An optimal MCID determination method is not yet established.
- Developing a useful method requires declared assumptions and methodology.
- Future MCID efforts should focus on specific external criteria tied to patient symptoms and interventions.
Related Concept Videos
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...